Revolution Medicines Stock Forecast

Stock Price Forecast

The 16 analysts that cover Revolution Medicines stock have a consensus rating of "Strong Buy" and an average price target of $100.13, which forecasts a 3.28% increase in the stock price over the next year. The lowest target is $64 and the highest is $170.

Price Target: $100.13 (+3.28%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$64	$100.13	$80	$170
Change	-33.99%	+3.28%	-17.48%	+75.35%

Analyst Ratings

The average analyst rating for Revolution Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	7	9	10	9	9	8
Buy	6	7	6	9	9	8
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	16	16	18	18	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jay Olson Oppenheimer	Oppenheimer	Buy Maintains $75 → $150	Buy	Maintains	$75 → $150	+54.72%	Jan 27, 2026
Laura Prendergast Stifel	Stifel	Strong Buy Maintains $85 → $170	Strong Buy	Maintains	$85 → $170	+75.35%	Jan 22, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $77 → $140	Buy	Maintains	$77 → $140	+44.40%	Jan 21, 2026
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Maintains $92 → $160	Strong Buy	Maintains	$92 → $160	+65.03%	Jan 20, 2026
Joseph Catanzaro Mizuho	Mizuho	Buy Maintains $90 → $143	Buy	Maintains	$90 → $143	+47.50%	Jan 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.22M

Revenue Next Year

35.47M

from 4.22M

740.40%

from 4.22M

EPS This Year

-5.71

from -3.58

EPS Next Year

-6.55

from -5.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	42.98M	29.39M	35.38M	11.58M	-	4.22M	35.47M
Revenue Growth	-14.10%	-31.62%	20.38%	-67.27%	-	-	740.40%
EPS	-2.01	-2.57	-3.08	-3.86	-3.58	-5.71	-6.55
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	43.8M	191.8M
Avg	4.2M	35.5M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	4,446.0%
Avg	-	740.4%
Low	-	-

EPS Forecast

EPS	2025	2026
High	-5.19	-4.71
Avg	-5.71	-6.55
Low	-5.64	-7.48

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.